Icatibant Acetate is a synthetic decapeptide that functions as a selective bradykinin B2 receptor antagonist, indicated for the treatment of acute attacks of hereditary angioedema. This pharmaceutical… Read more
Icatibant Acetate is a synthetic decapeptide that functions as a selective bradykinin B2 receptor antagonist, indicated for the treatment of acute attacks of hereditary angioedema. This pharmaceutical compound works by blocking bradykinin binding to its receptor, thereby mitigating the swelling and inflammation associated with this condition. This category provides essential reference standards for Icatibant Acetate, including its active pharmaceutical ingredient, along with related impurities, metabolites, and stable isotope-labelled compounds. These materials are critical for pharmaceutical laboratories engaged in rigorous analytical testing, impurity profiling, and method validation. By utilizing these precisely characterized reference materials, scientists can ensure accurate quantification, confirm structural integrity, and maintain high standards of quality control throughout the pharmaceutical development and manufacturing process.